References
Akhtar A, Xiaoyan Wang S, Ghali L, Bell C, Wen X (2017). Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers. Journal of biomedical research 31 (3): 177-188.
Akıl E, Akıl MA, Varol S, Özdemir HH, Yücel Y, Arslan D, et al. (2014). Echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio are novel inflammatory predictors of cerebral ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 23 (9): 2328-2334.
Au WY, Kumana CR, Kou M, Mak R, Chan GC, Lam CW, et al. (2003). Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia. Blood102 (1): 407-408.
Babu CS, Ramanathan M (2011). Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience29 (1): 93-105.
Bellosta S, Corsini A (2018). Statin drug interactions and related adverse reactions: an update.17 (1): 25-37.
Chen Y, Huang W, Yang M, Xin G, Cui W, Xie Z, et al. (2017). Cardiotonic Steroids Stimulate Macrophage Inflammatory Responses Through a Pathway Involving CD36, TLR4, and Na/K-ATPase. Arteriosclerosis, thrombosis, and vascular biology37 (8): 1462-1469.
Christ A, Günther P, Lauterbach MAR, Duewell P, Biswas D, Pelka K, et al. (2018). Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell172 (1-2): 162-175.e114.
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. (2010). NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464 (7293):1357-1361.
Fang S, Wan X, Zou X, Sun S, Hao X, Liang C, et al. (2021). Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway. Cell death & disease12 (1): 88.
Febbraio M, Guy E, Silverstein RL (2004). Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology 24 (12): 2333-2338.
Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, et al. (2000). Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. The Journal of clinical investigation105 (8): 1049-1056.
Güleç Başer B, İslimye Taşkın M, Adalı E, Öztürk E, Hısmıoğulları AA, Yay A (2018). Does progesterone have protective effects on ovarian ischemia-reperfusion injury?Journal of the Turkish German Gynecological Association19 (2): 87-93.
Grines CL (2015). Acute coronary syndromes: Acute MI in women–the fountain of youth has run dry.Nature reviews. Cardiology 12 (6): 322-323.
Hansson GK, Hermansson A (2011). The immune system in atherosclerosis. Nature immunology12 (3): 204-212.
Hansson GK, Libby P, Tabas I (2015). Inflammation and plaque vulnerability. Journal of internal medicine 278 (5): 483-493.
Hazen SL, Smith JD (2012). An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport.Circulation research 111 (8): 948-950.
Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016). Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.Circulation research 118 (4): 535-546.
Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H (2018). NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. 233 (3):2116-2132.
Huang L, Chambliss KL, Gao X, Yuhanna IS, Behling-Kelly E, Bergaya S, et al. (2019). SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.Nature 569 (7757): 565-569.
Kataoka Y, Puri R, Nicholls SJ (2015). Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging. Cardiovascular diagnosis and therapy 5 (4): 280-289.
Kauser K, Sonnenberg D, Diel P, Rubanyi GM (1998). Effect of 17beta-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. British journal of pharmacology 123 (6): 1089-1096.
Kavurma MM, Rayner KJ, Karunakaran D (2017). The walking dead: macrophage inflammation and death in atherosclerosis. Current opinion in lipidology28 (2): 91-98.
Koelwyn GJ, Corr EM, Erbay E (2018). Regulation of macrophage immunometabolism in atherosclerosis.19 (6): 526-537.
Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. (2014). Effects of extended-release niacin with laropiprant in high-risk patients.The New England journal of medicine 371 (3):203-212.
Latz E, Duewell P (2018). NLRP3 inflammasome activation in inflammaging. Seminars in immunology40: 61-73.
Li H, Jiao Y, Xie M (2017). Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation. Inflammation 40 (6):2042-2051.
Monaco C, Paleolog E (2004). Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovascular research 61 (4):671-682.
Munshi NC (2001). Arsenic trioxide: an emerging therapy for multiple myeloma. The oncologist6 Suppl 2: 17-21.
Navab M, Reddy ST, Van Lenten BJ, Fogelman AM (2011). HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nature reviews. Cardiology8 (4): 222-232.
Nicholson AC, Han J, Febbraio M, Silversterin RL, Hajjar DP (2001). Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Annals of the New York Academy of Sciences 947: 224-228.
Ouimet M, Barrett TJ, Fisher EA (2019). HDL and Reverse Cholesterol Transport. Circulation research 124 (10): 1505-1518.
Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, et al. (2007). Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.Circulation 115 (4): 450-458.
Seneviratne AN, Edsfeldt A, Cole JE, Kassiteridi C, Swart M, Park I, et al. (2017). Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis. Circulation136 (12): 1140-1154.
Shen L, Gong F, Tian W, Li W, Zhang F, Qian J, et al. (2013). Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model. BioMed research international 2013: 937936.
Subbarayan PR, Ardalan B (2014). In the war against solid tumors arsenic trioxide needs partners.Journal of gastrointestinal cancer 45 (3):363-371.
Tak PP, Firestein GS (2001). NF-kappaB: a key role in inflammatory diseases. The Journal of clinical investigation 107 (1): 7-11.
Tam LS, Kitas GD, González-Gay MA (2014). Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?Rheumatology (Oxford, England) 53 (6):1108-1119.
Tang T, Gong T, Jiang W, Zhou R (2018). GPCRs in NLRP3 Inflammasome Activation, Regulation, and Therapeutics. Trends in pharmacological sciences39 (9): 798-811.
Tie C, Gao K, Zhang N, Zhang S, Shen J, Xie X, et al. (2015). Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition. PloS one 10 (11): e0142430.
Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, et al. (2012). Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochemical and biophysical research communications 425 (2):162-168.
Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, et al. (2004). Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circulation research94 (4): 534-541.
Zhang K, Zhao P, Guo G, Guo Y, Tian L, Sun X, et al. (2016). Arsenic Trioxide Attenuates NF-κB and Cytokine mRNA Levels in the Livers of Cocks. Biological trace element research 170 (2): 432-437.
Zhang R, Han S (2018). Cereal Fiber Ameliorates High-Fat/Cholesterol-Diet-Induced Atherosclerosis by Modulating the NLRP3 Inflammasome Pathway in ApoE(-/-) Mice.66 (19): 4827-4834.
Zhang S, Zhang Y, Li S, Li Z (2017). Efficacy of arsenic trioxide drug-eluting stents in the treatment of coronary heart disease. Experimental and therapeutic medicine13 (4): 1634-1636.
Zhao D, Tong L, Zhang L, Li H, Wan Y, Zhang T (2016). Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice. Molecular medicine reports14 (6): 4983-4990.
Zhao Y, Du R, Zhou T, Yang D, Huang Y, Wang Y, et al. (2018). Arsenic Trioxide-Coated Stent Is an Endothelium-Friendly Drug Eluting Stent. 7 (15):e1800207.
Zhao Y, Zang G, Yin T, Ma X, Zhou L, Wu L, et al. (2021). A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway.Bioactive materials 6 (2): 375-385.